George Adi Mor bought $20k of CMMB
Chief Executive Officer at Chemomab Therapeutics Ltd.. 9,804 shares at an average of $2.07, traded May 29, 2026, filed Jun 1, 2026.
Score components
- +25RoleCEO
- 0Trade size$20k at market
- +3Relative to holdingsHoldings up 8%
- +8Price context63% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001178913-26-003004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 29, 2026 | POpen-market purchase American Depositary Shares | -4,878 | $2.05 | $10,000 | 134,205 | Jun 1, 2026 |
| May 29, 2026 | POpen-market purchase American Depositary Shares | -4,926 | $2.08 | $10k | 139,131 | Jun 1, 2026 |
| May 29, 2026 | JOther American Depositary Shares | -31,712 | - | - | 31,712 | Jun 1, 2026 |
| May 29, 2026 | JOther American Depositary Shares | -18,750 | - | - | 18,750 | Jun 1, 2026 |
Related signals
Other insiders at Chemomab Therapeutics Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | CMMBsell Chemomab Therapeutics Ltd. | Neil Harris Cohen director | $6,516 2,304 shares | -7% | |
| 28Weak | Chemomab Therapeutics Ltd. | Neil Harris Cohen director | $4,818 2,409 shares | -19% | |
| 68Notable | Chemomab Therapeutics Ltd. | George Adi Mor Chief Scientific Officer | $1.2M 582,023 shares | -90% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.